Hepatocyte‐specific <scp>RAP1B</scp> deficiency ameliorates high‐fat diet‐induced obesity and liver inflammation in mice
This study highlights RAP1B's pivotal role in hepatic metabolism and positions it as a potential therapeutic target for obesity and related metabolic disorders.
Authors
- Yaping Zhou (ORCID: https://orcid.org/0000-0002-0659-1687)
- Yinxu Fu (ORCID: https://orcid.org/0009-0004-0810-6974)
- Yanyang Hu (ORCID: https://orcid.org/0000-0001-8915-0125)
- Qiongya Zhao (ORCID: https://orcid.org/0000-0001-9616-4787)
- Kaiqiang Yang
- Liqin Jin (ORCID: https://orcid.org/0000-0002-1351-1948)
- Ping Hu (ORCID: https://orcid.org/0000-0001-6770-4190)
- E. R. Gritskevitch
- Jianxin Lyu (ORCID: https://orcid.org/0000-0003-2343-1666)
- Weijia Li (ORCID: https://orcid.org/0009-0009-2064-3437)
- Yu Fang (ORCID: https://orcid.org/0000-0002-5169-364X)
- Yu Shi (ORCID: https://orcid.org/0000-0003-3180-9008)
- Ting Fu (ORCID: https://orcid.org/0000-0003-3518-6469)
Institutions
- Wenzhou Medical University (CN)
- Belarusian State University (BY)
- Zhejiang Provincial People's Hospital (CN)
- Hangzhou Medical College (CN)
- International Sakharov Environmental Institute (BY)
Publication Details
- Journal
- Diabetes Obesity and Metabolism
- Published
- 2025-03-13
- DOI
- https://doi.org/10.1111/dom.16309
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China